Edvenswa Enterprises Limited has announced the fixation of remuneration for its Managing Director, Mr. Uppuluri Sreenivasa Sreekanth. Effective November 1, 2026, the MD will receive ₹33,333 per month, amounting to ₹4,00,000 per annum. This follows a period where he served without remuneration. The approval is subject to shareholder and other necessary approvals, with other terms of appointment remaining unchanged.
Edvenswa Enterprises Approves Managing Director’s Remuneration
Edvenswa Enterprises Limited has officially approved the fixation of remuneration for its Managing Director, Mr. Uppuluri Sreenivasa Sreekanth. This significant decision was made by the Board of Directors at a meeting held on November 13, 2026, based on the recommendation of the Nomination and Remuneration Committee. Mr. Sreekanth, who also serves as Chairman and is a Promoter and Executive of the company, had previously been serving in his position without remuneration.
New Compensation Structure
The newly approved remuneration package for the Managing Director is set at ₹33,333 per month, which translates to an annual compensation of ₹4,00,000. This new remuneration is effective from November 1, 2026. The approval is contingent upon obtaining the necessary consent from the company’s shareholders and any other statutory approvals required under the Companies Act, 2013.
Appointment Details
The company’s filing also clarified details regarding Mr. Sreekanth’s appointment. He was initially appointed for a term of 5 years, effective May 26, 2022, and his tenure is set to conclude on May 25, 2027. The announcement specified that all other terms and conditions of his existing appointment will remain unaltered, with the change solely pertaining to his remuneration.
Disclosure Compliance
This disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and relevant circulars from SEBI. The company has provided the required particulars concerning the change in remuneration, ensuring compliance with regulatory mandates. The information has also been made available on the company’s official website.
Source: BSE
